Evidence map›Paper›PMID 42645270›Full record

ArticleBiomimetics (Basel, Switzerland)2026

Epilepsy Detected Using a New Method Based on Volumetric Analysis Results from Brain MR Images.

Orhan Bölükbaş, Harun Uğuz

Abstract read
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Orhan BölükbaşDepartment of Computer Engineering, Konya Technical University, Konya 42250, Turkey.
Harun UğuzDepartment of Computer Engineering, Konya Technical University, Konya 42250, Turkey.ORCID 0000-0003-4617-202X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is a challenging brain disease that requires significant clinical findings. (1) Background: The aim of this study is to improve the success rate of epilepsy detection using a newly developed method by optimizing the high-dimensional dataset obtained from brain MRI images. Standard machine learning models fall short of achieving the desired success in high-dimensional datasets. To achieve this, we aimed to develop an optimized hybrid model by combining the local classification power of the k-Nearest Neighbor classifier and the anomaly detection success of the negative selection algorithm. (2) Methods: Cortical and subcortical brain regions were analyzed to examine volumetric differences. A dataset was created by identifying regions statistically significant for epilepsy. This dataset was then optimized using the Scatter Search Snake Optimization algorithm. The performances of six different machine learning models trained on this optimized dataset were compared. (3) Results: The standard and popular models, SVM (82.70%), kNN (78.70%), RF (69.30%), MLP (73.30%), and NSA (95.89%), demonstrated a detection success rate. In contrast, the proposed hybrid model, kNN-NSA (98.65%), demonstrated a detection success rate. (4) Conclusions: The optimized hybrid kNN-NSA approach, which considers local density in such high-dimensional datasets and tolerates outliers within the self-data, appears to outperform traditional methods. Furthermore, this study has demonstrated that volumetric differences in regions not previously reported in the literature, such as WM-hypointensities, ventral DC, and choroid plexus, may be effective in the decision-making process for diagnosing epilepsy, as they are also found to be significant.

Indexed as

anomaly detectionbrain volumeepilepsyfeature selectionnegative selection algorithm

Identifiers

PMID42645270
PMCPMC13509262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.